Tribio InVivoMAb Anti-Human ALK-1 & VEGF Bispecific Antibody (TBS10490)
$479.00 – $1,919.00
| SKU | Stock | SIZE (mg) | Price | Quantity | ||
|---|---|---|---|---|---|---|
| TBS10490-100 | Yes | 100 UG | $479.00 | |||
| TBS10490-1 | Yes | 1 MG | $1,919.00 |
- Description
- Terms
- Additional information
- Reviews (0)
Description
Description: Tribio InVivoMAb Anti-Human ALK-1 & VEGF Bispecific Antibody is a research bispecific antibody that targets ALK-1 (ACVRL1) and VEGF to inhibit angiogenesis by blocking both endothelial ALK-1 signaling and VEGF-driven vascular growth. It is mainly used in preclinical cancer and vascular biology studies to evaluate dual anti-angiogenic strategies in tumor models.
Applications: ELISA, FuncS
Species reactivity: Human
Host species: Human
Target: Bispecific, Serine/threonine-protein kinase receptor R3, SKR3, 2.7.11.30, Activin receptor-like kinase 1, ALK-1, TGF-B superfamily receptor type I, TSR-I, ACVRL1, ACVRLK1, ALK1, Vascular endothelial growth factor A, long form, L-VEGF, Vascular permeability factor, VPF, N-VEGF, VEGFA, VEGFA, VEGF
Isotype: IgG
Accession/UniProt: P37023 & P15692
Concentration: 3 mg/ml
Purity: >95%
Formulation: Liquid
Storage buffer: 0.01M PBS, pH 7.4
Purification: Protein A/G purified from cell culture supernatant.
Clonality: Monoclonal
Storage: Avoid repeated freeze-thaw cycles. -20°C for 12 months; -80°C for long-term storage.
Research use only.
Additional information
| SIZE (mg) | 1 MG, 100 UG |
|---|
Be the first to review “Tribio InVivoMAb Anti-Human ALK-1 & VEGF Bispecific Antibody (TBS10490)”
You must be logged in to post a review.
Reviews
There are no reviews yet.